Systolic Blood Pressure Trajectory, Frailty, and All-Cause Mortality >80 Years of Age: Cohort Study Using Electronic Health Records

Circulation

Volumn 135, Issue 24, 2017, Pages 2357-2368

  Ravindrarajah, Rathi ^a   Hazra, Nisha C ^a   Hamada, Shota ^a,b   Charlton, Judith ^a   Jackson, Stephen H D ^a   Dregan, Alex ^a,c   Gulliford, Martin C ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Tokyu Toranomon Bldg   (Japan)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

antihypertensive treatment; elderly; frailty; hypertension; mortality; primary care

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT;

AGE; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COMORBIDITY; DEMENTIA; ELECTRONIC HEALTH RECORD; FEMALE; FOLLOW UP; FRAILTY; GENERAL PRACTICE; GERIATRIC CARE; HUMAN; HYPERTENSION; ILLNESS TRAJECTORY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; OBESITY; PRESCRIPTION; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SEX; SMOKING; SYSTOLIC BLOOD PRESSURE; UNDERWEIGHT; UNITED KINGDOM; VERY ELDERLY; BLOOD PRESSURE; EPIDEMIOLOGY; FRAIL ELDERLY; MORTALITY; PHYSIOLOGY; TRENDS;

AGED, 80 AND OVER; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; COHORT STUDIES; ELECTRONIC HEALTH RECORDS; FEMALE; FOLLOW-UP STUDIES; FRAIL ELDERLY; HUMANS; MALE; MORTALITY; UNITED KINGDOM;

EID: 85018665862     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.116.026687     Document Type: Article

References (49)

1. Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation. 2003;107:2864-2869. doi: 10. 1161/01. CIR. 0000069826. 36125. B4.
2. Dregan A, Ravindrarajah R, Hazra N, Hamada S, Jackson SH, Gulliford MC. Longitudinal trends in hypertension management and mortality among octogenarians: prospective cohort study. Hypertension. 2016;68:97-105. doi: 10. 1161/HYPERTENSIONAHA. 116. 07246.
3. Staessen JA, Gasowski J, Wang JG, Thijs L, Hond ED, Boissel J-P, Coope J, Ekbom T, Gueyffier F, Liu L, Kerlikowske K, Pocock S and Fagard RH. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet. 2000;355:865-872.
4. Liu L, Wang JG, Gong L, Liu G, Staessen JA. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group. J Hypertens. 1998;16(12 Pt 1):1823-1829.
5. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhäger WH, Bulpitt CJ, de Leeuw PW, Dollery CT, Fletcher AE, Forette F, Leonetti G, Nachev C, O'Brien ET, Rosenfeld J, Rodicio JL, Tuomilehto J, Zanchetti A. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension: the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet. 1997;350:757-764.
6. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, Stoyanovsky V, Antikainen RL, Nikitin Y, Anderson C, Belhani A, Forette F, Rajkumar C, Thijs L, Banya W, Bulpitt CJ; HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887-1898. doi: 10. 1056/NEJMoa0801369.
7. Williamson JD, Supiano MA, Applegate WB, Berlowitz DR, Campbell RC, Chertow GM, Fine LJ, Haley WE, Hawfield AT, Ix JH, Kitzman DW, Kostis JB, Krousel-Wood MA, Launer LJ, Oparil S, Rodriguez CJ, Roumie CL, Shorr RI, Sink KM, Wadley VG, Whelton PK, Whittle J, Woolard NF, Wright JT Jr, Pajewski NM; SPRINT Research Group. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ?75 years: a randomized clinical trial. JAMA. 2016;315:2673-2682. doi: 10. 1001/jama. 2016. 7050.
8. Dahlöf B, Lindholm LH, Hansson L, Schersthén B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet. 1991;338:1281-1285.
9. Party MW. Medical Research Council trial of treatment of hypertension in older adults: principal results: MRC Working Party. BMJ. 1992;304:405-412.
10. Molander L, Lövheim H, Norman T, Nordström P, Gustafson Y. Lower systolic blood pressure is associated with greater mortality in people aged 85 and older. J Am Geriatr Soc. 2008;56:1853-1859. doi: 10. 1111/j. 1532-5415. 2008. 01948. x.
11. Hakala SM, Tilvis RS, Strandberg TE. Blood pressure and mortality in an older population: a 5-year follow-up of the Helsinki Ageing Study. Eur Heart J. 1997;18:1019-1023.
12. Guo Z, Viitanen M, Winblad B. Low blood pressure and five-year mortality in a Stockholm cohort of the very old: possible confounding by cognitive impairment and other factors. Am J Public Health. 1997;87:623-628.
13. Satish S, Freeman DH Jr, Ray L, Goodwin JS. The relationship between blood pressure and mortality in the oldest old. J Am Geriatr Soc. 2001;49:367-374.
14. van Bemmel T, Gussekloo J, Westendorp RG, Blauw GJ. In a population-based prospective study, no association between high blood pressure and mortality after age 85 years. J Hypertens. 2006;24:287-292. doi: 10. 1097/01. hjh. 0000200513. 48441. 8e.
15. Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381:752-762. doi: 10. 1016/S0140-6736(12)62167-9.
16. Morley JE. Hypertension: is it overtreated in the elderly? J Am Med Dir Assoc. 2010;11:147-152. doi: 10. 1016/j. jamda. 2009. 12. 081.
17. Pajewski NM, Williamson JD, Applegate WB, Berlowitz DR, Bolin LP, Chertow GM, Krousel-Wood MA, Lopez-Barrera N, Powell JR, Roumie CL, Still C, Sink KM, Tang R, Wright CB, Supiano MA; SPRINT Study Research Group. Characterizing frailty status in the Systolic Blood Pressure Intervention Trial. J Gerontol A Biol Sci Med Sci. 2016;71:649-655. doi: 10. 1093/gerona/ glv228.
18. Warwick J, Falaschetti E, Rockwood K, Mitnitski A, Thijs L, Beckett N, Bulpitt C, Peters R. No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a doubleblind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over. BMC Med. 2015;13:78. doi: 10. 1186/s12916-015-0328-1.
19. Odden MC, Peralta CA, Haan MN, Covinsky KE. Rethinking the association of high blood pressure with mortality in elderly adults: the impact of frailty. Arch Intern Med. 2012;172:1162-1168. doi: 10. 1001/archinternmed. 2012. 2555.
20. Clegg A, Bates C, Young J, Ryan R, Nichols L, Ann Teale E, Mohammed MA, Parry J, Marshall T. Development and validation of an electronic frailty index using routine primary care electronic health record data. Age Ageing. 2016;45:353-360. doi: 10. 1093/ageing/ afw039.
21. Herrett E, Gallagher AM, Bhaskaran K, Forbes H, Mathur R, van Staa T, Smeeth L. Data resource profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol. 2015;44:827-836. doi: 10. 1093/ije/dyv098.
22. Sever P. New hypertension guidelines from the National Institute for Health and Clinical Excellence and the British Hypertension Society. J Renin Angiotensin Aldosterone Syst. 2006;7:61-63. doi: 10. 3317/jraas. 2006. 011.
23. Booth HP, Prevost AT, Gulliford MC. Validity of smoking prevalence estimates from primary care electronic health records compared with national population survey data for England, 2007 to 2011. Pharmacoepidemiol Drug Saf. 2013;22:1357-1361. doi: 10. 1002/pds. 3537.
24. Ravindrarajah R, Dregan A, Hazra NC, Hamada S, Jackson SHD, Gulliford MC. Declining blood pressure and intensification of blood pressure management among people over 80 years: cohort study using electronic health records. J Hypertens. 2017;35:1276-1282. doi:10. 1097/HJH. 0000000000001291.
25. Tanner RM, Shimbo D, Seals SR, Reynolds K, Bowling CB, Ogedegbe G, Muntner P. White-coat effect among older adults: data from the Jackson Heart Study. J Clin Hypertens (Greenwich). 2016;18:139-145. doi: 10. 1111/jch. 12644.
26. Bakris GL. The implications of blood pressure measurement methods on treatment targets for blood pressure. Circulation. 2016;134:904-905. doi: 10. 1161/CIRCULATIONAHA. 116. 022536.
27. Xue QL. The frailty syndrome: definition and natural history. Clin Geriatr Med. 2011;27:1-15. doi: 10. 1016/j. cger. 2010. 08. 009.
28. Mitnitski A, Fallah N, Rockwood MR, Rockwood K. Transitions in cognitive status in relation to frailty in older adults: a comparison of three frailty measures. J Nutr Health Aging. 2011;15:863-867.
29. Cigolle CT, Ofstedal MB, Tian Z, Blaum CS. Comparing models of frailty: the Health and Retirement Study. J Am Geriatr Soc. 2009;57:830-839. doi: 10. 1111/j. 1532-5415. 2009. 02225. x.
30. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA; Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146-M156.
31. Rockwood K. Conceptual models of frailty: accumulation of deficits. Can J Cardiol. 2016;32:1046-1050. doi: 10. 1016/j. cjca. 2016. 03. 020.
32. van Iersel MB, Rikkert MG. Frailty criteria give heterogeneous results when applied in clinical practice. J Am Geriatr Soc. 2006;54:728-729. doi: 10. 1111/j. 1532-5415. 2006. 0066814.x.
33. Collerton J, Martin-Ruiz C, Davies K, Hilkens CM, Isaacs J, Kolenda C, Parker C, Dunn M, Catt M, Jagger C, von Zglinicki T, Kirkwood TB. Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old: cross-sectional findings from the Newcastle 85+ Study. Mech Ageing Dev. 2012;133:456-466. doi: 10. 1016/j. mad. 2012. 05. 005.
34. Rockwood K, Andrew M, Mitnitski A. A comparison of two approaches to measuring frailty in elderly people. J Gerontol A Biol Sci Med Sci. 2007;62:738-743.
35. Office of National Statistics. National Life Tables: England. London: Office for National Statistics, 2016. https://www. ons. gov. uk/peoplepopulationandcommunity/birthsdeathsandmarriages/ lifeexpectancies/bulletins/nationallifetablesunitedkingdom/ 20132015. Accessed February 20, 2017.
36. Office for National Statistics. Estimates of the Very Old (including Centenarians): England and Wales, and United Kingdom, 2002-2015. London: Office for National Statistics, 2016. https://www. ons. gov. uk/peoplepopulationandcommunity/ birthsdeathsandmarriages/ageing/bulletins/estimatesofthevery oldincludingcentenarians/2002to2015. Accessed February 20, 2017.
37. Boshuizen HC, Izaks GJ, van Buuren S, Ligthart GJ. Blood pressure and mortality in elderly people aged 85 and older: community based study. BMJ. 1998;316:1780-1784.
38. Adamsson Eryd S, Gudbjörnsdottir S, Manhem K, Rosengren A, Svensson AM, Miftaraj M, Franzén S, Björck S. Blood pressure and complications in individuals with type 2 diabetes and no previous cardiovascular disease: national population based cohort study. BMJ. 2016;354:i4070.
39. Rastas S, Pirttilä T, Viramo P, Verkkoniemi A, Halonen P, Juva K, Niinistö L, Mattila K, Länsimies E, Sulkava R. Association between blood pressure and survival over 9 years in a general population aged 85 and older. J Am Geriatr Soc. 2006;54:912-918. doi: 10. 1111/j. 1532-5415. 2006. 00742. x.
40. Nilsson SE, Read S, Berg S, Johansson B, Melander A, Lindblad U. Low systolic blood pressure is associated with impaired cognitive function in the oldest old: longitudinal observations in a population-based sample 80 years and older. Aging Clin Exp Res. 2007;19:41-47.
41. Benetos A, Labat C, Rossignol P, Fay R, Rolland Y, Valbusa F, Salvi P, Zamboni M, Manckoundia P, Hanon O, Gautier S. Treatment with multiple blood pressure medications, achieved blood pressure, and mortality in older nursing home residents: the PARTAGE Study. JAMA Intern Med. 2015;175:989-995. doi: 10. 1001/jamainternmed. 2014. 8012.
42. Musini VM, Tejani AM, Bassett K, Wright JM. Pharmacotherapy for hypertension in the elderly. Cochrane Database Syst Rev. 2009:4:CD000028.
43. Benetos A, Rossignol P, Cherubini A, Joly L, Grodzicki T, Rajkumar C, Strandberg TE, Petrovic M. Polypharmacy in the aging patient: management of hypertension in octogenarians. JAMA. 2015;314:170-180. doi: 10. 1001/jama. 2015. 7517.
44. Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol. 2004;43:1439-1444. doi: 10. 1016/j. jacc. 2003. 11. 039.
45. Klassen PS, Lowrie EG, Reddan DN, DeLong ER, Coladonato JA, Szczech LA, Lazarus JM, Owen WF Jr. Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA. 2002;287:1548-1555.
46. Diehr P, Williamson J, Burke GL, Psaty BM. The aging and dying processes and the health of older adults. J Clin Epidemiol. 2002;55:269-278.
47. Palmore E, Cleveland W. Aging, terminal decline, and terminal drop. J Gerontol. 1976;31:76-81.
48. Siegler IC. The terminal drop hypothesis: fact or artifact? Exp Aging Res. 1975;1:169-185. doi: 10. 1080/03610737508257957.
49. Diehr P, Williamson J, Patrick DL, Bild DE, Burke GL. Patterns of self-rated health in older adults before and after sentinel health events. J Am Geriatr Soc. 2001;49:36-44.